Screener
Charles River Laboratories CRL Manufacturing — Goodwill impairment
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.
The source filing: Charles River Laboratories’s 10-K, filed February 18, 2026.
- Filed
- Feb 18, 2026, 9:21 AM EST
- Fiscal year
- FY2025
- Accession
- 0001100682-26-000022
| Line item | Fiscal Year / December 27, 2025 | Fiscal Year / December 28, 2024 | Fiscal Year / December 30, 2023 |
|---|---|---|---|
| Selling, general and administrative | 142,101 | 132,803 | 146,311 |
| Amortization of intangible assets | 104,778 | 52,471 | 45,392 |
| Intangible asset impairment | 108,974 | — | — |
| Goodwill impairment | 165,000 | 215,000 | — |
| Operating income (loss) | $(184,284) | $(71,453) | $88,329 |
| Unallocated Corporate (1) | |||
| Selling, general and administrative | $259,676 | $258,121 | $231,810 |
| Operating loss | $(259,676) | $(258,121) | $(231,810) |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Charles River Laboratories's manufacturing — goodwill impairment?
- Charles River Laboratories (CRL) reported manufacturing — goodwill impairment of $41.25M in Q4 2025.
- How has Charles River Laboratories's manufacturing — goodwill impairment changed year-over-year?
- Charles River Laboratories's manufacturing — goodwill impairment decreased by 23.3% year-over-year, from $53.75M to $41.25M.
- What does manufacturing — goodwill impairment mean?
- A non-cash charge recorded when the fair value of the manufacturing reporting unit falls below its carrying value, necessitating a reduction in the recorded goodwill. This indicates a reassessment of the segment's future earnings potential.
Ask your AI about Charles River Laboratories's manufacturing — goodwill impairment.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude